NDAQ:FGEN - Post Discussion
FibroGen Inc
> FibroGen To Host Part I of Virtual KOL Investor Event Series
Post by
whytestocks on Feb 05, 2024 12:15pm
FibroGen To Host Part I of Virtual KOL Investor Event Series
News; $FGEN FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024 | BenzingaSAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced it will host Part I of a virtual KOL investor even...
FGEN - FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024 | Benzinga
Be the first to comment on this post